0001639837-22-000001.txt : 20220517 0001639837-22-000001.hdr.sgml : 20220517 20220517163008 ACCESSION NUMBER: 0001639837-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220517 DATE AS OF CHANGE: 20220517 EFFECTIVENESS DATE: 20220517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trethera Corp CENTRAL INDEX KEY: 0001639837 IRS NUMBER: 462817645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-445983 FILM NUMBER: 22934964 BUSINESS ADDRESS: STREET 1: 3201 WILSHIRE BLVD. STREET 2: SUITE 102 CITY: SANTA MONICA STATE: CA ZIP: 90403 BUSINESS PHONE: 310-997-2788 MAIL ADDRESS: STREET 1: 3201 WILSHIRE BLVD. STREET 2: SUITE 102 CITY: SANTA MONICA STATE: CA ZIP: 90403 FORMER COMPANY: FORMER CONFORMED NAME: Triangle Therapeutics Inc. DATE OF NAME CHANGE: 20150416 D 1 primary_doc.xml X0708 D LIVE 0001639837 Trethera Corp 13547 Ventura Blvd. Suite 363 Los Angeles CA CALIFORNIA 91423 310-997-2788 DELAWARE Triangle Therapeutics Inc. Corporation true Carl W. McKinzie 13547 Ventura Blvd. Suite 363 Los Angeles CA CALIFORNIA 91423 Executive Officer Director Jean B. deKernion 13547 Ventura Blvd. Suite 363 Los Angeles CA CALIFORNIA 91423 Executive Officer Director Timothy Donahue, M.D. 13547 Ventura Blvd. Suite 363 Los Angeles CA CALIFORNIA 91423 Director Louis L. Gonda 13547 Ventura Blvd. Suite 363 Los Angeles CA CALIFORNIA 91423 Director Kenneth A. Schultz, M.D. 13547 Ventura Blvd. Suite 363 Los Angeles CA CALIFORNIA 91423 Executive Officer Director Biotechnology Decline to Disclose 06b false 2021-06-26 false true true true false 0 Indefinite 3833592 Indefinite false 38 0 0 0 false Trethera Corp /s/ Kenneth A. Schultz Kenneth A. Schultz, M.D. CEO 2022-05-17